STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa

BACKGROUND: Pompe disease is one of the few neuromuscular diseases with an approved drug therapy, which has been available since 2006. Our study aimed to determine the real-world long-term efficacy and safety of alglucosidase alfa. METHODS: This multicenter retrospective study (NCT02824068) collecte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neurol
Auteurs principaux: Gutschmidt, Kristina, Musumeci, Olimpia, Díaz-Manera, Jordi, Chien, Yin-Hsiu, Knop, Karl Christian, Wenninger, Stephan, Montagnese, Federica, Pugliese, Alessia, Tavilla, Graziana, Alonso-Pérez, Jorge, Hwu, Paul Wuh-Liang, Toscano, Antonio, Schoser, Benedikt
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2021
Sujets:
Original Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7862044/
https://ncbi.nlm.nih.gov/pubmed/33543425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-021-10409-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires